Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED)

Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED)
复制标题

DOI:
10.1055/s-0031-1291491
复制
发表时间:
2012-01-01
期刊:
影响因子:
9.3
通讯作者:
Kuipers, E. J.
Kuipers, E. J.
中科院分区:
医学1区
文献类型:
--
作者:
Dinis-Ribeiro, M.;Areia, M.;Kuipers, E. J.

文献摘要

被引文献

相似文献

萎缩性胃炎、肠化生和胃上皮发育不良是常见的,并且与胃癌的风险增加有关。在缺乏指南的情况下,对这些癌前病变患者的管理存在很大的差异。因此,欧洲胃肠内窥镜学会(ESGE)、欧洲幽门螺杆菌研究组(EHSG)、欧洲病理学会(ESP)和葡萄牙消化内窥镜学会(SPED)共同努力制定了针对癌前病变和胃病变(MAPS)患者管理的循证指南。一个由来自24个国家的63名专家组成的多学科小组通过重复在线投票和2011年6月在葡萄牙波尔图举行的会议制定了这些建议。这些建议强调了胃萎缩和化生患者的癌症风险增加,以及在高度不典型增生的情况下需要适当的分期,并侧重于治疗和监测适应症和方法。
Atrophic gastritis, intestinal metaplasia, and epithelial dysplasia of the stomach are common and are associated with an increased risk for gastric cancer. In the absence of guidelines, there is wide disparity in the management of patients with these premalignant conditions. The European Society of Gastrointestinal Endoscopy (ESGE), the European Helicobacter Study Group (EHSG), the European Society of Pathology (ESP) and the Sociedade Portuguesa de Endoscopia Digestiva (SPED) have therefore combined efforts to develop evidence-based guidelines on the management of patients with precancerous conditions and lesions of the stomach (termed MAPS). A multidisciplinary group of 63 experts from 24 countries developed these recommendations by means of repeat online voting and a meeting in June 2011 in Porto, Portugal. The recommendations emphasize the increased cancer risk in patients with gastric atrophy and metaplasia, and the need for adequate staging in the case of high grade dysplasia, and they focus on treatment and surveillance indications and methods.